Biological messiness vs. biological genius: Mechanistic aspects and roles of protein promiscuity

Journal of Steroid Biochemistry and Molecular Biology

Volumn 151, Issue , 2015, Pages 3-11

  Atkins, William M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Detoxication enzymes; Enzyme evolution; Enzyme promiscuity; Evolvability; Intrinsically Disordered proteins

Indexed keywords

PROTEIN; ENZYME;

BEHAVIOR; BIOCHEMISTRY; BIOTECHNOLOGY; COMPARATIVE STUDY; DETOXIFICATION; ENZYMOLOGY; EVOLUTION; IMMUNITY; IN VITRO STUDY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ENZYME SPECIFICITY; METABOLISM;

ENZYMES; PROTEINS; SUBSTRATE SPECIFICITY;

EID: 84938874123     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2014.09.010     Document Type: Review

References (74)

1. [1] Neurath, H., Walsh, K.A., Role of proteolytic enzymes in biological regulation (a review). Proc. Natl. Acad. Sci. U. S. A. 73:11 (1976), 3825–3832.
2. [2] Fersht, A., Winter, G., Protein engineering. Trends Biochem. Sci. 17:8 (1992), 292–295.
3. [3] Russell, A.J., Fersht, A.R., Rational modification of enzyme catalysis by engineering surface charge. Nature 328:6130 (1987), 496–500.
4. [4] Fersht, A.R., Shi, J.P., Knill-Jones, J., Lowe, D.M., Wilkinson, A.J., Blow, D.M., Brick, P., Carter, P., Waye, M.M., Winter, G., Hydrogen bonding and biological specificity analysed by protein engineering. Nature 314:6008 (1985), 235–238.
5. [5] Sinha, N., Smith-Gill, S.J., Electrostatics in protein binding and function. Curr. Protein Pept. Sci. 3:6 (2002), 601–614.
6. [6] Perona, J.J., Hadd, A., Structural diversity and protein engineering of the aminoacyl-tRNA synthetases. Biochemistry 51:44 (2012), 8705–8729.
7. [7] Pocker, Y., Guilbert, L.J., Catalytic versatility of erythrocyte carbonic anhydrase. Kinetic studies of the enzyme-catalyzed hydrolysis of methyl pyridyl carbonates. Biochemistry 11:2 (1972), 180–190.
8. [8] Pocker, Y., Meany, J.E., The catalytic versatility of erythrocyte carbonic anhydrase. II. Kinetic studies of the enzyme-catalyzed hydration of pyridine aldehydes. Biochemistry 6:1 (1967), 239–246.
9. [9] Khersonsky, O., Tawfik, D.S., Enzyme promiscuity: a mechanistic and evolutionary perspective. Annu. Rev. Biochem. 79 (2010), 471–505.
10. [10] Tokuriki, N., Tawfik, D.S., Protein dynamism and evolvability. Science 324:5924 (2009), 203–207.
11. [11] Nobeli, I., Favia, A.D., Thornton, J.M., Protein promiscuity and its implications for biotechnology. Nat. Biotechnol. 27:2 (2009), 157–167.
12. [12] Basu, M.K., Poliakov, E., Rogozin, I.B., Domain mobility in proteins: functional and evolutionary implications. Brief Bioinform. 10:3 (2009), 205–216.
13. [13] Tawfik, D.S., Messy biology and the origins of evolutionary innovations. Nat. Chem. Biol. 6:10 (2010), 692–696.
14. [14] Glasner, M.E., Gerlt, J.A., Babbitt, P.C., Mechanisms of protein evolution and their application to protein engineering. Adv. Enzymol Relat. Areas Mol. Biol. 75 (2007), 193–239.
15. [15] Noy, N., Ligand specificity of nuclear hormone receptors: sifting through promiscuity. Biochemistry 46:47 (2007), 13461–13467.
16. [16] Giuseppe, M., Luigia, M., Elena, P., Yan, F., Luigi, M., Enzyme promiscuity in the hormone-sensitive lipase family of proteins. Protein Pept. Lett. 19:2 (2012), 144–154.
17. [17] Mohamed, M.F., Hollfelder, F., Efficient, crosswise catalytic promiscuity among enzymes that catalyze phosphoryl transfer. Biochim. Biophys. Acta. 1834:1 (2013), 417–424.
18. [18] Lin, F., Das, D., Lin, X.N., Marsh, E.N., Aldehyde-forming fatty acyl-CoA reductase from cyanobacteria: expression, purification and characterization of the recombinant enzyme. FEBS J. 280:19 (2013), 4773–4781.
19. [19] Roskoski, R. Jr., ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol. Res. 66:2 (2012), 105–143.
20. [20] Di Cera, E., Serine proteases. IUBMB Life 61:5 (2009), 510–515.
21. [21] Guy, J.L., Lambert, D.W., Warner, F.J., Hooper, N.M., Turner, A.J., Membrane-associated zinc peptidase families: comparing ACE and ACE2. Biochim. Biophys. Acta. 1751:1 (2005), 2–8.
22. [22] Huntington, J.A., Thrombin plasticity. Biochim. Biophys. Acta. 1824:1 (2012), 246–252.
23. [23] Liu, Y., Lv, T., Ren, J., Wang, M., Wu, Q., Zhu, D., The catalytic promiscuity of a microbial 7α-hydroxysteroid dehydrogenase. Reduction of non-steroidal carbonyl compounds. Steroids 76:10–11 (2011), 1136–1140.
24. [24] Eick, G.N., Colucci, J.K., Harms, M.J., Ortlund, E.A., Thornton, J.W., Evolution of minimal specificity and promiscuity in steroid hormone receptors. PLoS Genet., 8(11), 2012, e1003072.
25. [25] Lathe, R., Kotelevtsev, Y., Steroid signaling: ligand-binding promiscuity, molecular symmetry, and the need for gating. Steroids 82 (2014), 14–22.
26. [26] Cook, D.L., Atkins, W.M., Enhanced detoxication due to distributive catalysis and toxic thresholds: a kinetic analysis. Biochemistry 36:36 (1997), 10801–10806.
27. [27] Guengerich, F.P., Mechanisms of cytochrome P450 substrate oxidation: MiniReview. J. Biochem. Mol. Toxicol. 21:4 (2007), 163–168.
28. [28] Armstrong, R.N., Structure, catalytic mechanism, and evolution of the glutathione transferases. Chem. Res. Toxicol. 10:1 (1997), 2–18.
29. [29] Bock, K.W., Human UDP-glucuronosyltransferases: feedback loops between substrates and ligands of their transcription factors. Biochem. Pharmacol. 84:8 (2012), 1000–1006.
30. [30] Allali-Hassani, A., Pan, P.W., Dombrovski, L., Najmanovich, R., Tempel, W., Dong, A., Loppnau, P., Martin, F., Thornton, J., Edwards, A.M., Bochkarev, A., Plotnikov, A.N., Vedadi, M., Arrowsmith, C.H., Structural and chemical profiling of the human cytosolic sulfotransferases. PLoS Biol., 5(5), 2007, e97.
31. [31] Roberts, A.G., Yang, J., Halpert, J.R., Nelson, S.D., Thummel, K.T., Atkins, W.M., The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4. Biochemistry 50:50 (2011), 10804–11018.
32. [32] Harrelson, J.P., Atkins, W.M., Nelson, S.D., Multiple-ligand binding in CYP2A6: probing mechanisms of cytochrome P450 cooperativity by assessing substrate dynamics. Biochemistry 47:9 (2008), 2978–2988.
33. [33] Darbyshire, J.F., Iyer, K.R., Grogan, J., Korzekwa, K.R., Trager, W.F., Substrate probe for the mechanism of aromatic hydroxylation catalyzed by cytochrome P450. Drug Metab. Dispos. 24:9 (1996), 1038–1045.
34. [34] Senior, A.E., Two ATPases. J. Biol. Chem. 287:36 (2012), 30049–30062.
35. [35] Schmitt, K.C., Rothman, R.B., Reith, M.E., Nonclassical pharmacology of the dopamine transporter: atypical inhibitors, allosteric modulators, and partial substrates. J. Pharmacol. Exp. Ther. 346:1 (2013), 2–10.
36. [36] Jasper, J.R., Insel, P.A., Evolving concepts of partial agonism. The beta-adrenergic receptor as a paradigm. Biochem. Pharmacol. 43:2 (1992), 119–130.
37. [37] Mark, W.Y., Liao, J.C., Lu, Y., Ayed, A., Laister, R., Szymczyna, B., Chakrabartty, A., Arrowsmith, C.H., Characterization of segments from the central region of BRCA1: an intrinsically disordered scaffold for multiple protein–protein and protein–DNA interactions?. J. Mol. Biol. 345:2 (2005), 275–287.
38. [38] Uversky, V.N., Oldfield, C.J., Dunker, A.K., Showing your ID: intrinsic disorder as an ID for recognition, regulation and cell signaling. J. Mol. Recognit. 18:5 (2005), 343–384.
39. [39] Kirschner, K., Bisswanger, H., Multifunctional proteins. Annu. Rev. Biochem. 45 (1976), 143–166.
40. [40] Cheng, X.Y., Huang, W.J., Hu, S.C., Zhang, H.L., Wang, H., Zhang, J.X., Lin, H.H., Chen, Y.Z., Zou, Q., Ji, Z.L., A global characterization and identification of multifunctional enzymes. PLoS One, 7(6), 2012, e38979.
41. [41] Kivirikko, K.I., Myllylä, R., Pihlajaniemi, T., Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four cosubstrates and a multifunctional subunit. FASEB J. 3:5 (1989), 1609–1617.
42. [42] Loenen, W.A., Dryden, D.T., Raleigh, E.A., Wilson, G.G., Type I restriction enzymes and their relatives. Nucleic Acids Res. 42:1 (2014), 20–44.
43. [43] Khersonsky, O., Tawfik, D.S., Mander, L., Lui, H.-W., (eds.) Comprehensive Natural Products II Chemistry and Biology, 8, 2010, Elsevier, Oxford, 48–90.
44. [44] Dellus-Gur, E., Toth-Petroczy, A., Elias, M., Tawfik, D.S., What makes a protein fold amenable to functional innovation? Fold polarity and stability trade-offs. J. Mol. Biol. 425:14 (2013), 2609–2621.
45. [45] Tokuriki, N., Jackson, C.J., Afriat-Jurnou, L., Wyganowski, K.T., Tang, R., Tawfik, D.S., Diminishing returns and tradeoffs constrain the laboratory optimization of an enzyme. Nat. Commun., 3, 2012, 1257.
46. [46] Chakraborty, S., An automated flow for directed evolution based on detection of promiscuous scaffolds using spatial and electrostatic properties of catalytic residues. PLoS One, 7(7), 2012, e40408.
47. [47] Williams, G.J., Zhang, C., Thorson, J.S., Expanding the promiscuity of a natural-product glycosyltransferase by directed evolution. Nat. Chem. Biol. 3:10 (2007), 657–662.
48. [48] Díaz Arenas, C., Cooper, T.F., Mechanisms and selection of evolvability: experimental evidence. FEMS Microbiol. Rev. 37:4 (2013), 572–582.
49. [49] Willis, J.R., Briney, B.S., DeLuca, S.L., Crowe, J.E. Jr., Meiler, J., Human germline antibody gene segments encode polyspecific antibodies. PLoS Comput. Biol., 9(4), 2013, e1003045.
50. [50] James, L.C., Roversi, P., Tawfik, D.S., Antibody multispecificity mediated by conformational diversity. Science 299:5611 (2003), 1362–1367.
51. [51] Castagnoli, L., Costantini, A., Dall'Armi, C., Gonfloni, S., Montecchi-Palazzi, L., Panni, S., Paoluzi, S., Santonico, E., Cesareni, G., Selectivity and promiscuity in the interaction network mediated by protein recognition modules. FEBS Lett. 567:1 (2004), 74–79.
52. [52] Dunker, A.K., Cortese, M.S., Romero, P., Iakoucheva, L.M., Uversky, V.N., Flexible nets. The roles of intrinsic disorder in protein interaction networks. FEBS J. 272:20 (2005), 5129–5148.
53. [53] Peggs, K.S., Allison, J.P., Co-stimulatory pathways in lymphocyte regulation: the immunoglobulin superfamily. Br. J. Haematol. 130:6 (2005), 809–824.
54. [54] Patil, A., Kinoshita, K., Nakamura, H., Domain distribution and intrinsic disorder in hubs in the human protein-protein interaction network. Protein Sci. 19:8 (2010), 1461–1468.
55. [55] Pollice, A., Vivo, M., La Mantia, G., The promiscuity of ARF interactions with the proteasome. FEBS Lett. 582:23–24 (2008), 3257–3262.
56. [56] Lee, J., Ozcan, U., Unfolded protein response signaling and metabolic diseases. J. Biol. Chem. 289:3 (2014), 1203–1211.
57. [57] Chakraborty, S., Rao, B.J., A measure of the promiscuity of proteins and characteristics of residues in the vicinity of the catalytic site that regulate promiscuity. PLoS One, 7(2), 2012, e32011.
58. [58] Chakraborty, S., Ásgeirsson, B., Rao, B.J., A measure of the broad substrate specificity of enzymes based on ‘duplicate' catalytic residues. PLoS One, 7(11), 2012, e49313.
59. [59] Chakraborty, S., Minda, R., Salaye, L., Dandekar, A.M., Bhattacharjee, S.K., Rao, B.J., Promiscuity-based enzyme selection for rational directed evolution experiments. Methods Mol. Biol. 978 (2013), 205–216.
60. [60] Carbonell, P., Faulon, J.L., Molecular signatures-based prediction of enzyme promiscuity. Bioinformatics 26:16 (2010), 2012–2019.
61. [61] Carbonell, P., Lecointre, G., Faulon, J.L., Origins of specificity and promiscuity in metabolic networks. J. Biol. Chem. 286:51 (2011), 43994–44004.
62. [62] Nath, A., Atkins, W.M., A quantitative index of substrate promiscuity. Biochemistry 47:1 (2008), 157–166.
63. [63] Nath, A., Zientek, M.A., Burke, B.J., Jiang, Y., Atkins, W.M., Quantifying and predicting the promiscuity and isoform specificity of small-molecule cytochrome P450 inhibitors. Drug Metab. Dispos. 38:12 (2010), 2195–2203.
64. [64] Durant, J.L., Leland, B.A., Henry, D.R., Norse, J.G., Reoptimization of MDL keys foruse in drug discovery. J. Chem. Inform. Comput. Sci. 42 (2002), 1273–1280.
65. [65] Honaker, M.T., Acchione, M., Zhang, W., Mannervik, B., Atkins, W.M., Enzymatic detoxication, conformational selection, and the role of molten globule active sites. J. Biol. Chem. 288:25 (2013), 18599–18611.
66. [66] Honaker, M.T., Acchione, M., Sumida, J.P., Atkins, W.M., Ensemble perspective for catalytic promiscuity: calorimetric analysis of the active site conformational landscape of a detoxification enzyme. J. Biol. Chem. 286:49 (2011), 42770–42776.
67. [67] Hou, L., Honaker, M.T., Shireman, L.M., Balogh, L.M., Roberts, A.G., Ng, K.C., Nath, A., Atkins, W.M., Functional promiscuity correlates with conformational heterogeneity in A-class glutathione S-transferases. J. Biol. Chem. 282:32 (2007), 23264–23274.
68. [68] Foti, R.S., Honaker, M., Nath, A., Pearson, J.T., Buttrick, B., Isoherranen, N., Atkins, W.M., Catalytic versus inhibitory promiscuity in cytochrome P450s: implications for evolution of new function. Biochemistry 50:13 (2011), 2387–2393.
69. [69] Khersonsky, O., Malitsky, S., Rogachev, I., Tawfik, D.S., Role of chemistry versus substrate binding in recruiting promiscuous enzyme functions. Biochemistry 50:13 (2011), 2683–2690.
70. [70] Gerlt, J.A., Babbitt, P.C., Enzyme (re)design: lessons from natural evolution and computation. Curr. Opin. Chem. Biol. 13:1 (2009), 10–18.
71. [71] Viney, M., Reece, S.E., Adaptive noise. Proc. Biol. Sci., 280(1767), 2013, 20131104.
72. [72] Simpson, M.L., Cox, C.D., Allen, M.S., McCollum, J.M., Dar, R.D., Karig, D.K., Cooke, J.F., Noise in biological circuits. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1:2 (2009), 214–225.
73. [73] Ladbury, J.E., Arold, S.T., Noise in cellular signaling pathways: causes and effects. Trends Biochem. Sci. 37:5 (2012), 173–178.
74. [74] Schreiber, G., Keating, A.E., Protein binding specificity versus promiscuity. Curr. Opin. Struct. Biol. 21:1 (2011), 50–61.